Atopic Dermatitis in Children
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Atopic dermatitis (AD) is a chronic, relapsing, highly pruritic skin condition resulting from disruption of the epithelial barrier and associated immune dysregulation in the skin of genetically predisposed hosts. AD generally develops in early childhood, has a characteristic age-dependent distribution and is commonly associated with elevated IgE, peripheral eosinophilia and other allergic diseases. Staphylococcus aureus colonization is common and may contribute to disease progression and severity. Targeted therapies to restore both impaired skin barrier and control inflammation are required for optimal outcomes for patients with moderate to severe disease. Pruritus is universal among patients with AD and has a dominant impact on diminishing quality of life. Medications such as anti-histamines have demonstrated poor efficacy in controlling AD-associated itch. Education of patients regarding the primary underlying defects and provision of a comprehensive skin care plan is essential for disease maintenance and management of flares.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic features of atopic dermatitis
Hanifin, J. M., & Rajka, G. (1980) · Acta Dermato-Venereologica · doi:10.2340/00015555924447 · Cited by 5,086
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960 · cited 2×
“dysfunction with predominant Th2 responses likely contribute.(18, 19) Specific IgE to staphylococcal enterotoxin has also been found in sera of AD patients and is associated with disease severity in children.”
BackgroundWILLIAMS, H. C., JBURNEY, P. G., HAY, R. J., ARCHER, C. B., SHIPLEY, M. J., AHUNTER, J. J., BINGHAM, E. A., FINLAY, A. Y., PEMBROKE, A. C., CGRAHAM-BROWN, R. A., et al. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb08530.x · Cited by 1,271
Filaggrin Mutations Associated with Skin and Allergic Diseases
Irvine, A. D., McLean, W. H. I., & Leung, D. Y. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011040 · Cited by 1,217 · cited 1×
“peanut allergy as well as asthma, with the latter only occurring among patients with comorbid AD, supporting a role for epicutaneous sensitization in systemic atopic disease.(41) Lyons et al.”
BackgroundA Direct Estimate of the Human αβ T Cell Receptor Diversity
Arstila, T. P., Casrouge, A., Baron, V., Even, J., Kanellopoulos, J., & Kourilsky, P. (1999) · Science · doi:10.1126/science.286.5441.958 · Cited by 931
Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema
Jungersted, J. M., Scheer, H., Mempel, M., Baurecht, H., Cifuentes, L., Høgh, J. K., Hellgren, L. I., Jemec, G. B. E., Agner, T., & Weidinger, S. (2010) · Allergy · doi:10.1111/j.1398-9995.2010.02326.x · Cited by 344
Mechanism of HBD-3 deficiency in atopic dermatitis
Howell, M. D., Boguniewicz, M., Pastore, S., Novak, N., Bieber, T., Girolomoni, G., & Leung, D. Y. M. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.08.008 · Cited by 208 · cited 1×
“(51) Additionally, IL-10, IL-4, and IL-13 have been shown to reduce antimicrobial peptide (AMP) expression in keratinocytes, and patients with AD have been shown to have a relative deficiency in AMP production.(19, 52, 53) This may contribute to staphylococcal colonization, increased risk for viral and bacterial super…”
BackgroundManagement of Atopic Dermatitis in the Pediatric Population
Krakowski, A. C., Eichenfield, L. F., & Dohil, M. A. (2008) · Pediatrics · doi:10.1542/peds.2007-2232 · Cited by 205
Interleukin-10 Downregulates Anti-Microbial Peptide Expression in Atopic Dermatitis
Howell, M. D., Novak, N., Bieber, T., Pastore, S., Girolomoni, G., Boguniewicz, M., Streib, J., Wong, C., Gallo, R. L., & Leung, D. Y. M. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23776.x · Cited by 193
Effect of moisturizers on epidermal barrier function
Lodén, M. (2012) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2011.08.015 · Cited by 161 · cited 1×
“topical corticosteroids to control flares, and reducing pruritus.(81, 83, 84) Occlusion is the primary desired function of emollients, with ointments being more effective than creams.”
Background
Cited by
Environmental risk factors and their role in the management of atopic dermatitis
Kantor, R., & Silverberg, J. I. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1212660 · Cited by 365
First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis
Myles, I. A., Earland, N. J., Anderson, E. D., Moore, I. N., Kieh, M. D., Williams, K. W., Saleem, A., Fontecilla, N. M., Welch, P. A., Darnell, D. A., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.120608 · Cited by 326
Li, X., Cao, Y., An, S.-J., Xiang, Y., Huang, H.-X., Xu, B., Zhang, Y., Li, Y.-F., Lu, Y.-G., & Cai, T.-J. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16607-2 · Cited by 13
Gu, H., Zhu, Y., Jia, T., Li, X., Lu, Y., & Kaku, K. (2020) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.13069 · Cited by 8
Thandi, C. S., Constantinou, S., Vincent, R., & Ridd, M. J. (2023) · Skin Health and Disease · doi:10.1002/ski2.213 · Cited by 5
Metadata
- Authors
- Lyons, J. J., Milner, J. D., & Stone, K. D.
- Venue
- Immunology and Allergy Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 35
- Issue
- 1
- Pages
- 161-183
- ISSN
- 0889-8561 (ISSN-L)
- OpenAlex
- W1678127861
- Cited by
- 228
- References
- 11
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Atopic Dermatitis in Children. https://app.cochat.ai/papers/10.1016/j.iac.2014.09.008
- The paper
- Lyons, J. J., Milner, J. D., & Stone, K. D. (2015). Atopic Dermatitis in Children. Immunology and Allergy Clinics of North America. https://doi.org/10.1016/j.iac.2014.09.008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.